Epstein–Barr virus latent membrane protein 2A has no growth-altering effects when expressed in differentiating epithelia

References

1. Burkhardt A. L., Bolen J. B., Kieff E., Longnecker R. 1992; An Epstein–Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. Journal of Virology 66:5161–5167
   [Google Scholar]
2. Caldwell R. G., Wilson J. B., Anderson S. J., Longnecker R. 1998; Epstein–Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9:405–411
   [Google Scholar]
3. Caldwell R. G., Brown R. C., Longnecker R. 2000; Epstein–Barr virus LMP2A-induced B-cell survival in two unique classes of EuLMP2A transgenic mice. Journal of Virology 74:1101–1113
   [Google Scholar]
4. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869
   [Google Scholar]
5. Cruchley A. T., Williams D. M., Niedobitek G., Young L. S. 1997; Epstein–Barr virus: biology and disease. Oral Diseases 3:Suppl. 1S156–S163
   [Google Scholar]
6. Fruehling S., Longnecker R. 1997; The immunoreceptor tyrosine-based activation motif of Epstein–Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology 235:241–251
   [Google Scholar]
7. Fruehling S., Lee S. K., Herrold R., Frech B., Laux G., Kremmer E., Grasser F. A., Longnecker R. 1996; Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. Journal of Virology 70:6216–6226
   [Google Scholar]
8. Fruehling S., Swart R., Dolwick K. M., Kremmer E., Longnecker R. 1998; Tyrosine 112 of latent membrane protein 2A is essential for protein tyrosine kinase loading and regulation of Epstein–Barr virus latency. Journal of Virology 72:7796–7806
   [Google Scholar]
9. Fuchs E., Byrne C. 1994; The epidermis: rising to the surface. Current Opinion in Genetics & Development 4:725–736
   [Google Scholar]
10. Guo L., Yu Q. C., Fuchs E. 1993; Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO Journal 12:973–986
    [Google Scholar]
11. Kaplan K. B., Swedlow J. R., Morgan D. O., Varmus H. E. 1995; c-Src enhances the spreading of src−/− fibroblasts on fibronectin by a kinase-independent mechanism. Genes & Development 9:1505–1517
    [Google Scholar]
12. Kieff E. 1996; Epstein–Barr virus and its replication. In Fields Virology pp 2343–2396 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
13. Knapp B., Rentrop M., Schweizer J., Winter H. 1987; Three cDNA sequences of mouse type I keratins. Cellular localization of the mRNAs in normal and hyperproliferative tissues. Journal of Biological Chemistry 262:938–945
    [Google Scholar]
14. Kulwichit W., Edwards R. H., Davenport E. M., Baskar J. F., Godfrey V., Raab-Traub N. 1998; Expression of the Epstein–Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice. Proceedings of the National Academy of Sciences, USA 95:11963–11968
    [Google Scholar]
15. Longnecker R. 1998; Molecular biology of Epstein–Barr virus. In Human Tumor Viruses pp 133–172 Edited by McCance D. Washington, DC: American Society for Microbiology;
    [Google Scholar]
16. Miller C. L., Lee J. H., Kieff E., Longnecker R. 1994; An integral membrane protein (LMP2) blocks reactivation of Epstein–Barr virus from latency following surface immunoglobulin crosslinking. Proceedings of the National Academy of Sciences, USA 91:772–776
    [Google Scholar]
17. Miller C. L., Burkhardt A. L., Lee J. H., Stealey B., Longnecker R., Bolen J. B., Kieff E. 1995; Integral membrane protein 2 of Epstein–Barr virus regulates reactivation from latency through dominant negative effects on protein tyrosine kinases. Immunity 2:155–166
    [Google Scholar]
18. Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R. 1982; The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 31:11–24
    [Google Scholar]
19. Morgan P. R., Su L. 1994; Intermediate filaments in oral neoplasia. I. Oral cancer and epithelial dysplasia. European Journal of Cancer, Part B, Oral Oncology 30:160–166
    [Google Scholar]
20. Raab-Traub N. 1992; Epstein–Barr virus and nasopharyngeal carcinoma. Seminars in Cancer Biology 3:297–307
    [Google Scholar]
21. Rickinson A. B., Kieff E. 1996; Epstein–Barr virus. In Fields Virology pp 2397–2446 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
22. Scholle F., Longnecker R., Raab-Traub N. 1999; Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein–Barr virus latent membrane protein 2: a role for C-terminal Src kinase. Journal of Virology 73:4767–4775
    [Google Scholar]
23. Stoler A., Kopan R., Duvic M., Fuchs E. 1988; Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. Journal of Cell Biology 107:427–446
    [Google Scholar]
24. Thomas S. M., Brugge J. S. 1997; Cellular functions regulated by Src family kinases. Annual Review of Cell and Developmental Biology 13:513–609
    [Google Scholar]
25. Turksen K., Kupper T., Degenstein L., Williams I., Fuchs E. 1992; Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proceedings of the National Academy of Sciences, USA 89:5068–5072
    [Google Scholar]
26. Vassar R., Hutton M. E., Fuchs E. 1992; Transgenic overexpression of transforming growth factor alpha bypasses the need for c-Ha-ras mutations in mouse skin tumorigenesis. Molecular and Cellular Biology 12:4643–4653
    [Google Scholar]
27. Weiss A., Littman D. R. 1994; Signal transduction by lymphocyte antigen receptors. Cell 76:263–274
    [Google Scholar]
28. Weiss R. A., Eichner R., Sun T. T. 1984; Monoclonal antibody analysis of keratin expression in epidermal diseases: a 48- and 56-kdalton keratin as molecular markers for hyperproliferative keratinocytes. Journal of Cell Biology 98:1397–1406
    [Google Scholar]
29. Wilson J. B., Weinberg W., Johnson R., Yuspa S., Levine A. J. 1990; Expression of the BNLF-1 oncogene of Epstein–Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 61:1315–1327
    [Google Scholar]
30. Wilson J. B., Bell J. L., Levine A. J. 1996; Expression of Epstein–Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO Journal 15:3117–3126
    [Google Scholar]